Volume 95 Issue 4 | pp. 31-32
Issue Date: January 23, 2017

Cover Stories: New directions for machine learning

Pharma partnership applies deep learning to very big data

GlaxoSmithKline teams with government labs 
on computational models for drug discovery
Department: Science & Technology
Keywords: pharmaceuticals, computational chemistry, computers, partnership, drug discovery, manufacturing

GlaxoSmithKline has for several years engaged in a campaign of creative destruction, acting to replace traditional methods of manufacturing and research with more efficient ways of doing things. The implementation of programs such as its Manufacturing Technology Roadmap, a manifesto against the standard pharma method of manufacturing drugs in batches, for example, has helped earn the company the reputation of risk-taker among major drug firms.

Now, GSK is turning its attention to drug discovery, where . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society